|
|
 |
 |
VersaFoam® Bibliography
Huang X, et al, A novel foam vehicle for delivery of topical corticosteroids. J Am Acad Dermatol, Vol 53, No 1, 2005 Jul: S26-S38
Rocco-Wood S, et al, A Randomized,Open-Label Study to Evaluate the Comparative Absorption of a Foam Formulation of Clindamycin Phosphate, 1% versus a Once-Daily Clindamycin Phosphate, 1% Topical Gel in Subjects with Acne Vulgaris. Poster presented at 2003 American Academy of Dermatology.
Spellman M.C., et al, Clindamycin phosphate foam, 1% versus clindamycin phosphate gel, 1%, for the treatment of acne vulgaris; Results of a Phase III study. Poster presented at 2004 American Academy of Dermatology.
Lenn J, et al, Anatomical region variations on the in vitro skin permeation of clobetasol propionate formulations, Poster presented at 2004 American Academy of Dermatology.
Lenn J, et al, Comparison of clobetasol propionate skin permeation and drug distribution in vitro from various topical drug delivery vehicles (foam, lotion, and wash-off shampoo). Poster presented at 2004 Summer American Academy of Dermatology.
Tanojo H, et al, Skin Penetration Profile of Clobetasol Propionate from Foam, Cream and Ointment. Poster presented at 2003 Summer American Academy of Dermatology.
Huang X, et al, Directional association of preclinical, vasoconstrictor assay and clinical results of topical clobetasol formulations. Poster presented at 2004 American Academy of Dermatology.
Tanojo H, et al, In Vitro Skin Permeation of Clobetasol Propionate Formulations on Different Anatomical Regions. Poster presented at 2004 American Association of Pharmaceutical Scientists.
Lenn J, et al, In Vitro Skin Penetration of Desonide and Clobetasol Propionate by Foam Formulations Compared With Other Topical Delivery Vehicles. Poster presented at 2004 American Association of Pharmaceutical Scientists. Poster presented at 2007 Las Vegas Dermatology Seminar.
Stein Gold L, et al, Efficacy and Safety of Clobetasol Propionate Emollient Formulation Foam, 0.05%, for the Treatment of Moderate to Severe Atopic Dermatitis and Mild to Moderate Plaque Type Psoriasis. Poster presented at 31st Hawaii Dermatology Seminar, 2007.
|
|
